EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
+5.4%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$2.5B
AUM Growth
+$2.5B
Cap. Flow
-$148M
Cap. Flow %
-5.91%
Top 10 Hldgs %
69.34%
Holding
73
New
8
Increased
7
Reduced
9
Closed
16

Top Buys

1
SRPT icon
Sarepta Therapeutics
SRPT
$93.6M
2
QURE icon
uniQure
QURE
$60M
3
SWTX
SpringWorks Therapeutics
SWTX
$56.4M
4
ZYME icon
Zymeworks
ZYME
$23.3M
5
XNCR icon
Xencor
XNCR
$18.7M

Top Sells

1
KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
$105M
2
CNTA
Centessa Pharmaceuticals
CNTA
$51.5M
3
VRDN icon
Viridian Therapeutics
VRDN
$44.6M
4
NUVB icon
Nuvation Bio
NUVB
$44M
5
PCVX icon
Vaxcyte
PCVX
$40.3M

Sector Composition

1 Healthcare 99.86%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRGX
26
DELISTED
CARGO Therapeutics
CRGX
$21.2M 0.8%
1,470,000
– –
MLTX icon
27
MoonLake Immunotherapeutics
MLTX
$3.78B
$18M 0.68%
+332,522
New +$18M
DNA icon
28
Ginkgo Bioworks
DNA
$671M
$17.1M 0.65%
+1,743,344
New +$17.1M
RNA icon
29
Avidity Biosciences
RNA
$6.12B
$16.2M 0.61%
557,576
-200,000
-26% -$5.82M
MRSN icon
30
Mersana Therapeutics
MRSN
$34.8M
$16.2M 0.61%
11,328,000
-8,036,688
-42% -$11.5M
TCRX icon
31
TScan Therapeutics
TCRX
$106M
$15.2M 0.57%
5,000,000
– –
ADAP
32
Adaptimmune Therapeutics
ADAP
$13.9M
$14.8M 0.56%
27,404,070
– –
KYMR icon
33
Kymera Therapeutics
KYMR
$3.1B
$14.1M 0.53%
+350,000
New +$14.1M
DYN icon
34
Dyne Therapeutics
DYN
$1.92B
$13.1M 0.49%
555,644
– –
BCYC
35
Bicycle Therapeutics
BCYC
$492M
$12.7M 0.48%
910,000
– –
AVIR icon
36
Atea Pharmaceuticals
AVIR
$275M
$11.2M 0.42%
3,341,653
-2,100,243
-39% -$7.04M
DAWN icon
37
Day One Biopharmaceuticals
DAWN
$766M
$10.9M 0.41%
862,068
– –
REPL icon
38
Replimune Group
REPL
$460M
$10.3M 0.39%
850,341
– –
ALGS icon
39
Aligos Therapeutics
ALGS
$75.1M
$10.2M 0.38%
255,573
– –
ATRA icon
40
Atara Biotherapeutics
ATRA
$88.7M
$7.08M 0.27%
532,134
+63,196
+13% +$841K
VERV
41
DELISTED
Verve Therapeutics
VERV
$7.05M 0.27%
1,250,000
– –
FATE icon
42
Fate Therapeutics
FATE
$115M
$5.03M 0.19%
+3,049,405
New +$5.03M
GLPG icon
43
Galapagos
GLPG
$2.06B
$4.26M 0.16%
155,006
– –
KLRS
44
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
$3.95M 0.15%
408,688
-10,885,897
-96% -$105M
KROS icon
45
Keros Therapeutics
KROS
$640M
$2.97M 0.11%
187,500
– –
RLAY icon
46
Relay Therapeutics
RLAY
$709M
$2.64M 0.1%
641,426
-1,858,574
-74% -$7.66M
DSGN icon
47
Design Therapeutics
DSGN
$339M
$2.63M 0.1%
426,683
+372,849
+693% +$2.3M
NUVB.WS icon
48
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
$2.56M 0.1%
963,333
– –
GBIO icon
49
Generation Bio
GBIO
$40.3M
$2.17M 0.08%
2,046,867
– –
PRME icon
50
Prime Medicine
PRME
$595M
$2.04M 0.08%
700,000
– –
1
2
3